Company · CIK 0001401040 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
DiaMedica Therapeutics Inc. · DMAC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 AForm 4 → | Aug 12, 4:23 pm EDT | Dietrich John PaulsPresident & CEO, Director | 60,200 | — | — | 128,791 | — | |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:48 pm EST | Zhenyu XiaoDirector, 10% Owner | 3,250 | $4.00 | $13,000 | 7,100 | +84.4% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:42 pm EST | Todd A. VerdoornChief Scientific Officer | 1,000 | $4.00 | $4,000 | 2,000 | +100% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:37 pm EST | Richard D. PilnikDirector | 6,250 | $4.00 | $25,000 | 23,838 | +35.5% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:31 pm EST | Dietrich John PaulsPresident and CEO, Director | 5,000 | $4.00 | $20,000 | 29,804 | +20.2% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:27 pm EST | James T. ParsonsDirector | 2,250 | $4.00 | $9,000 | 6,100 | +58.4% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:22 pm EST | Scott KellenCFO and Secretary | 1,250 | $4.00 | $5,000 | 3,290 | +61.3% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:17 pm EST | Randall Michael GiuffreDirector | 11,250 | $4.00 | $45,000 | 85,804 | +15.1% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:08 pm EST | Harry W Alcorn Jr.Chief Medical Officer | 1,000 | $4.00 | $4,000 | 1,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 AForm 4 → | Jun 3, 5:28 pm EDT | Randall Michael GiuffreDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:27 pm EDT | Richard KuntzDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:27 pm EDT | Daniel J. O'ConnorDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:26 pm EDT | Tanya LewisDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:26 pm EDT | Charles Pauling SembaDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:24 pm EDT | James T. ParsonsDirector | 51,189 | — | — | 51,189 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:23 pm EDT | Dietrich John PaulsPresident & CEO, Director | 380,000 | — | — | 380,000 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:23 pm EDT | Scott KellenCFO & Secretary | 162,000 | — | — | 162,000 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:22 pm EDT | Julie KropChief Medical Officer | 67,500 | — | — | 67,500 | — |